BioAge Labs BIOA
NASDAQ BIOA
$5.87 +0.09 (+1.56%)
At close: Nov 11, 2026 · 4:00 PM EST

BioAge Labs (BIOA) Non-Current Deferred Revenue (2024 - 2026)

Updated

Analysis

BioAge Labs (BIOA) Non-Current Deferred Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BioAge Labs 265.60 Mn -1.75 Bn -21.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.63 Mn
Jun 30, 2026 4.36 Mn
Mar 31, 2026 6.19 Mn
Sep 30, 2025 556,000.00
Jun 30, 2025 1.90 Mn
Mar 31, 2025 3.23 Mn
Dec 31, 2024 4.67 Mn
API Access

BioAge Labs Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BIOA&period=max&api_key=YOUR_API_KEY